JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (4): 98-102.doi: 10.6040/j.issn.1673-3770.0.2016.228

Previous Articles     Next Articles

Clinical manifestations of polypoidal choroidal vasculopathy.

YAN Xin, WANG Cui, ZHAO Bojun   

  1. Deparment of Ophthalmology, Shandong Provincial Hospital affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2016-05-19 Online:2017-08-16 Published:2017-08-16

Abstract: Objective To investigate the demographic features and clinical manifestations of polypoidal choroidal vasculopathy(PCV). Methods We retrospectively reviewed 107 eyes in 87 consecutive outpatients with a diagnosis of PCV in the Department of Ophthalmology, Shandong Provincial Hospital from August 11, 2011 to January 28, 2015. All the patients underwent an epidemiological inquiry, routine eye examination, color fundus photography fluorescein angiography and indocyanine green angiography(ICGA). Results Among the 87 PCV patients, there was a male predominance with 50(57.5%)male patients. 67(77.0%)patients were affected unilaterally. The average age was 66.4±9.4 years old(range, 41-92). Based on fundus examination, the commonest clinical fundus feature was hemorrhagic pigment epithelial detachment(PED)(55 eyes, 51.4%), which was followed by sub-retinal orange-red bulging lesions(49 eyes, 45.8%). ICGA showed that polyps located in the macular area in 83(77.6%)eyes. The average number of polypoidal lesions was 2.71±1.79(ranged from 1 to 8). The mean area of the solitary polyp and the largest one of multiple polyps was 0.52±0.35 mm2, 0.49±0.37 mm2 respectively. Conclusion Among our patients with PCV, male, unilateral, macular location of polypoidal lesions with hemorrhagic PED and sub-retinal orange-red bulging lesion are the commonest clinical fundus manifestations. In ICGA, the mean area of PCV with solitary polyp was larger than the biggest one of PCV with multiple polyps.

Key words: Polypoidal choroidal vasculopathy, Fluorescein fundus angiography, Indocyanine green angiography, Clinical manifestation

CLC Number: 

  • R774
[1] Imamura Y, Engelbert M, Iida T, et al. Polypoidal choroidal vasculopathy: a review[J]. Surv Ophthalmol, 2010, 55(6):501-515.
[2] Laude A, Cackett PD, Vithana EN, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?[J]. Prog Retin Eye Res, 2010, 29(1):19-29.
[3] Byeon SH, Lee SC, Oh HS, et al. Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients[J]. Jpn J Ophthalmol, 2008, 52(1):57-62.
[4] Honda S, Matsumiya W, Negi A. Polypoidal choroidal vasculopathy: clinical features and genetic predisposition[J]. Ophthalmologica, 2014, 231(2):59-74.
[5] Wong RL, Lai TY. Polypoidal choroidal vasculopathy: an update on therapeutic approaches[J]. J Ophthalmic Vis Res, 2013, 8(4):359-371.
[6] Maruko I, Iida T, Saito M, et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients[J]. Am J Ophthalmol, 2007, 144(1):15-22.
[7] Liu Y, Wen F, Huang S, et al. Subtype lesions of neovascular age-related macular degeneration in Chinese patients[J]. Graefes Arch Clin Exp Ophthalmol, 2007, 245(10):1441-1445.
[8] Cackett P, Wong D, Yeo I. A classification system for polypoidal choroidal vasculopathy[J]. Retina, 2009, 29(2):187-191.
[9] Tsujikawa A, Nakanishi H, Ojima Y, et al. Macular polypoidal choroidal vasculopathy with a remote lesion[J]. Clin Exp Ophthalmol, 2008, 36(9):817-823.
[10] Kwok AK, Lai TY, Chan CW, et al. Polypoidal choroidal vasculopathy in Chinese patients[J]. Br J Ophthalmol, 2002, 86(8):892-897.
[11] Yamaoka S, Okada AA, Sugahara M, et al. Clinical features of polypoidal choroidal vasculopathy and visual outcomes in the absence of classic choroidal neovascularization[J]. Ophthalmologica, 2010, 224(3):147-152.
[12] Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy[M]. Japanese: Nippon Ganka Gakkai Zasshi, 2005:417-427.
[13] Tan CS, Ngo WK, Chen JP, et al. EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2015, 99(5):624-628.
[14] Hou J, Tao Y, Li XX, et al. Clinical characteristics of polypoidal choroidal vasculopathy in Chinese patients[J]. Graefes Arch Clin Exp Ophthalmol, 2011, 249(7):975-979.
[15] Wen F, Chen C, Wu D, et al. Polypoidal choroidal vasculopathy in elderly Chinese patients[J]. Graefes Arch Clin Exp Ophthalmol, 2004, 242(8):625-629.
[16] Lafaut BA, Leys AM, Snyers B, et al. Polypoidal choroidal vasculopathy in Caucasians[J]. Graefes Arch Clin Exp Ophthalmol, 2000, 238(9):752-759.
[17] Yannuzzi LA, Wong DW, Sforzolini BS, et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration[J]. Arch Ophthalmol, 1999, 117(11):1503-1510.
[18] Ciardella AP, Donsoff IM, Huang SJ, et al. Polypoidal choroidal vasculopathy[J]. Surv Ophthalmol, 2004, 49(1):25-37.
[19] Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics[J]. Arch Ophthalmol, 2003, 121(10):1392-1396.
[20] Hayashi H, Yamashiro K, Gotoh N, et al. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation[J]. Invest Ophthalmol Vis Sci, 2010, 51(11):5914-5919.
[21] 刘会娟, 陈中山, 丁琴, 等. 362例息肉样脉络膜血管病变患者的临床特征分析[J]. 中华眼底病杂志, 2013, 29(4):376-379. LIU Huijuan, CHEN Zhongshan, DING Qin, et al. Clinical characteristics of 362 cases of polypoidal choroidal vasculopathy[J]. Chin J Ocul Fund Dis, 2013, 29(4):376-379.
[22] 刘冉, 李加青, 曾婧, 等. 渗出型老年性黄斑变性与息肉样脉络膜血管病变患者年龄、性别及发病眼别的比较[J]. 中华眼底病杂志, 2012, 28(5):445-448. LIU Ran, LI Jiaqing, ZENG Jing, et al. Compare neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in age at diagnosis, gender and disease laterality[J]. Chin J Ocul Fund Dis, 2012, 28(5):445-448.
[23] Scassellati-Sforzolini B, Mariotti C, Bryan R, et al. Polypoidal choroidal vasculopathy in Italy[J]. Retina, 2001, 21(2):121-125.
[24] Mori K, Horie-Inoue K, Gehlbach PL, et al. Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population[J]. Ophthalmology, 2010, 117(5):928-938.
[25] Cackett P, Htoon H, Wong D, et al. Haemorrhagic pigment epithelial detachment as a predictive feature of polypoidal choroidal vasculopathy in a Chinese population[J]. Eye(Lond), 2010, 24(5):789-792.
[26] 史雪辉, 魏文斌, 田蓓, 等. 脉络膜新生血管的病变特征分析[J]. 中华眼科杂志, 2008, 44(9):780-785. SHI Xuehui, WEI Wenbin, TIAN Bei, et al. Analysis of clinical features of choroidal neovascularization[J]. Chin J Ophthalmol, 2008, 44(9):780-785.
[27] Yeung L, Chen SN. Polypoidal choroidal vasculopathy in Taiwan[J]. Chang Gung Med J, 2004, 27(5):366-372.
[28] Cheung CM, Laude A, Wong W, et al. Improved specificity of polypoidal choroidal vasculopathy diagnosis using a modified everest criteria[J]. Retina, 2015, 35(7):1375-1380.
[29] Suzuki M, Nagai N, Shinoda H, et al. Distinct responsiveness to intravitreal ranibizumab therapy in polypoidal choroidal vasculopathy with single or multiple polyps[J]. Am J Ophthalmol, 2016, 166:52-59.
[1] WANG Xian, LI Ying, ZHAO Bojun. Advances in diagnosis and treatment of polypoid choroidal vasculopathy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 103-106.
[2] LÜ Dan, LI Mingxia, MA Lanzhi, ZHANG Xinyuan, XIAO Hao, CHEN Fei, LIU Jun, LI Zhen. Neurofibromatosis of the head and neck involving the mediastinum: two cases report [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 82-86.
[3] DU Ran, WANG Jialin, WANG Yanling. Different clinical manifestations of retinitis pigmentosa and related imaging features [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 87-90.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!